High treatment adherence, satisfaction, motivation, and health-related quality of life with fingolimod in patients with relapsing-remitting multiple sclerosis - results from a 24-month, multicenter, open-label Danish study

一项为期 24 个月的丹麦多中心开放标签研究显示，芬戈莫德治疗复发缓解型多发性硬化症患者的治疗依从性、满意度、积极性和健康相关生活质量均较高。